Speaker illustration

Doctor David Mutschlechner

Mistelbach-Gaenserndorf Hospital, Mistelbach (Austria)

Member of:

European Society of Cardiology

Elderly patients are hyperresponsive to potent P2Y12 inhibitors

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Data-driven decisions for anticoagulant and antiplatelet therapy

Thumbnail

Cardiovascular events in patients treated with bempedoic acid vs. placebo: systematic review and meta-analysis

Event: ESC Congress 2024

Topic: Drug therapy

Session: Lipid-lowering therapies: new findings

Thumbnail